New patent for Kadmon Pharms drug REZUROCK

   November 20, 2021    Comments Off on New patent for Kadmon Pharms drug REZUROCK    Posted in: Patent Added

Annual Drug Patent Expirations for REZUROCK Rezurock is a drug marketed by Kadmon Pharms Llc and is included in one NDA. The generic ingredient in REZUROCK is belumosudil mesylate. Additional…

The post New patent for Kadmon Pharms drug REZUROCK appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog